A nucleoside analogue that is being screened as a potential anticancer agent causes gout in clinical trials. Which of the following actions of this drug may cause gout?
A) inhibits carbamoyl phosphate synthetase
B) inhibits the conversion of dihydrofolate to tetrahydrofolate
C) inhibits xanthine oxidase
D) interferes with feedback control of phosphoribosylpyrophosphate (PRPP) synthesis
E) interferes with feedback control of thymidylate synthase
Correct Answer:
Verified
Q10: A 37-year-old man presents with tophaceous deposits
Q11: The initial reaction of the de novo
Q12: Severe combined immunodeficiency disease (SCID) is characterized
Q13: Following a relatively normal early developmental period,
Q14: You are attending to a patient who
Q16: Which of the following groups of amino
Q17: Ribose-5-phosphate is activated for participation in nucleotide
Q18: In the synthesis of pyrimidines, which of
Q19: A 30-year-old man comes to the ER
Q20: A 10-year-old boy who has begun chemotherapy
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents